HIDTI: integration of heterogeneous information to predict drug-target interactions

Identification of drug-target interactions (DTIs) plays a crucial role in drug development. Traditional laboratory-based DTI discovery is generally costly and time-consuming. Therefore, computational approaches have been developed to predict interactions between drug candidates and disease-causing proteins. We designed a novel method, termed heterogeneous information integration for DTI prediction (HIDTI), based on the concept of predicting vectors for all of unknown/unavailable heterogeneous drug- and protein-related information. We applied a residual network in HIDTI to extract features of such heterogeneous information for predicting DTIs, and tested the model using drug-based ten-fold cross-validation to examine the prediction performance for unseen drugs. As a result, HIDTI outperformed existing models using heterogeneous information, and was demonstrating that our method predicted heterogeneous information on unseen data better than other models. In conclusion, our study suggests that HIDTI has the potential to advance the field of drug development by accurately predicting the targets of new drugs.

Automated summary

We developed a novel method called HIDTI for predicting interactions between drugs and disease-causing proteins. By using a residual network to extract features from heterogeneous information, our method accurately predicts the targets of new drugs.